Infusion reactions to the chimeric EGFR inhibitor cetuximab—change to the fully human anti-EGFR monoclonal antibody panitumumab is safe
Autor: | T. Sliwa, Beate Mayrbäurl, R. Schaberl-Moser, G. Resch, Richard Greil, Josef Thaler, G. Kopetzky, P. Kier, Werner Scheithauer, Thomas Nösslinger |
---|---|
Rok vydání: | 2011 |
Předmět: |
Cetuximab
business.industry Panitumumab Antibodies Monoclonal Antineoplastic Agents Hematology Antibodies Monoclonal Humanized ErbB Receptors Oncology medicine Cancer research Humans Neoplasm Metastasis Anti-EGFR Monoclonal Antibody Colorectal Neoplasms Infusions Intravenous business EGFR inhibitors medicine.drug |
Zdroj: | Annals of Oncology. 22:486-487 |
ISSN: | 0923-7534 |
DOI: | 10.1093/annonc/mdq744 |
Databáze: | OpenAIRE |
Externí odkaz: |